Cannabis Law Report

NOVEMBER 24, 2021

At the same time, the outlook on cannabis research data is largely positive. Chronic pain or pain were the conditions most frequently mentioned in articles about cannabis, followed by epilepsy, cancer or cancer pain, and nausea and chemotherapy. 2018 ; Frankhauser 2008 ). Refractory paediatric epilepsy. Cancer pain.

Research and Development 52

Research and Development Medicine Access Media 52

SMPL

MAY 26, 2020

And though a few outliers responded well to CBD alone, GW’s data showed that for relieving pain and inflammation, helping with sleep and alleviating seizures and spasms, most patients got the most benefit from an equal mix of CBD and THC — a drug the company called Sativex. But the research wasn’t enough.

CBD 40

CBD Research and Development Pharmaceutical Seed-To-Sale 40

NORML

AUGUST 26, 2019

These were moms and dads and grandparents of children [with intractable epilepsy] who were using medical cannabis oils. As in, no to anyone who wasn’t an epilepsy patient.]. ” and “We only want to see data from an American source.” They were all fine with that?

Marijuana 205

Marijuana Legalization Programs Oil 205